Growth Metrics

Integra Lifesciences Holdings (IART) Net Income Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.11%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4,440.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn 81.75%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 81.75%
Dec 31, 2025 -108.77%
Sep 30, 2025 49.47%
Jun 30, 2025 -3,803.18%
Mar 31, 2025 -670.89%
Dec 31, 2024 -2.01%
Sep 30, 2024 -154.85%
Jun 30, 2024 -396.41%
Mar 31, 2024 -113.54%
Dec 31, 2023 -62.54%
Sep 30, 2023 -60.94%
Jun 30, 2023 -90.66%
Mar 31, 2023 -26.37%
Dec 31, 2022 16.66%
Sep 30, 2022 15.47%
Jun 30, 2022 27.72%
Mar 31, 2022 -27.52%
Dec 31, 2021 -51.07%
Sep 30, 2021 33.68%
Jun 30, 2021 9,603.52%
Mar 31, 2021 394.49%
Dec 31, 2020 505.42%
Sep 30, 2020 217.12%
Jun 30, 2020 -101.24%
Mar 31, 2020 -71.97%
Dec 31, 2019 -39.06%
Sep 30, 2019 -307.67%
Jun 30, 2019 161.39%
Mar 31, 2019 198.00%
Dec 31, 2018 -43.33%
Sep 30, 2018 320.86%
Jun 30, 2018 4.99%
Mar 31, 2018 71.91%
Jun 30, 2015 -245.53%
Mar 31, 2015 -251.77%
Dec 31, 2014 -105.09%
Sep 30, 2014 102.69%
Jun 30, 2014 217.43%
Mar 31, 2014 136.60%
Dec 31, 2013 398.17%
Sep 30, 2013 -329.58%
Jun 30, 2013 -82.15%
Mar 31, 2013 -190.06%
Dec 31, 2012 180.39%
Sep 30, 2012 17.50%
Jun 30, 2012 1,118.03%
Mar 31, 2012 -41.73%
Dec 31, 2011 -75.75%
Sep 30, 2011 -31.79%
Jun 30, 2011 -95.39%
Mar 31, 2011 -24.54%
Dec 31, 2010 175.94%
Sep 30, 2010 14.21%
Jun 30, 2010 35.03%